Difference between revisions of "Corona Vaccins First Dose Efficacy"
From Tech
Jump to navigationJump to search| Line 1: | Line 1: | ||
=Pfizer= |
=Pfizer= |
||
[https://www.nejm.org/doi/full/10.1056/nejmoa2034577 Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine] |
[https://www.nejm.org/doi/full/10.1056/nejmoa2034577 Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine] |
||
| + | |||
| − | [[File:Screenshot_2021-07-11_at_11-28-03_Safety_and_Efficacy_of_the_BNT162b2_mRNA_Covid-19_Vaccine_NEJM.png||Efficacy of BNT162b2 (Pfizer) against Covid-19 after the First Dose.]] |
+ | [[File:Screenshot_2021-07-11_at_11-28-03_Safety_and_Efficacy_of_the_BNT162b2_mRNA_Covid-19_Vaccine_NEJM.png|x200px|Efficacy of BNT162b2 (Pfizer) against Covid-19 after the First Dose.]] |
=Moderna= |
=Moderna= |
||
[https://www.fda.gov/media/144434/download#page=28 Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020] |
[https://www.fda.gov/media/144434/download#page=28 Vaccines and Related Biological Products Advisory Committee MeetingDecember 17, 2020] |
||
| − | [[File:Screenshot 2021-07-11 at 11-43-02 Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Bri-...-.png||Cumulative Incidence Curves for the First COVID-19 Occurrence After Randomization, mITT Set]] |
+ | [[File:Screenshot 2021-07-11 at 11-43-02 Vaccines and Related Biological Products Advisory Committee December 17, 2020 Meeting Bri-...-.png|x200px|Cumulative Incidence Curves for the First COVID-19 Occurrence After Randomization, mITT Set]] |
